Jul 29, 2014
IMBRUVICA®, a jointly developed therapy from Pharmacyclics, Inc. and Janssen Biotech received full Approval based on Phase 3 RESONATE™ study data
Jul 28, 2014
Abbvie is a global biopharmaceutical specializing in the discovery and advancement of innovative therapies to meet the health needs of people and societies around the globe.
Jul 25, 2014
Gilead Sciences, Inc. is a biopharmaceutical company whose main focus is centered on discovering, developing and commercializing innovative therapeutics in areas of unmet medical need.
Jul 24, 2014
Biogen Idec specializes in the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders.
Jul 23, 2014
As one of the industry leaders in the healthcare sector, Novartis retains a positive Q2 report.
Jul 22, 2014
AstraZeneca is global pioneer in the biopharmaceutical industry specializing in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.
Jul 21, 2014
Anacor is a biopharmaceutical company whose focus is towards the discovery, development and commercialization of small molecule therapeutics derived from its novel boron chemistry platform.
Jul 18, 2014
Boehringer Ingelheim Pharmaceuticals is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and a member of the Boehringer Ingelheim group of companies.
Jul 17, 2014
Pfizer's acquisition of InnoPharma is an innovative move which is a part of the Global Established Pharma business and includes the manufacturing, production and sale of the products.
Jul 16, 2014
Johnson & Johnson a proven industry leader in the healthcare sector is the first big pharma corporation to unveil the second quarter results for 2014. The pharmaceuticals division made an impressive contribution to the strong sales growth.